CERT 250117 10.00C (CERT250117C10000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CERT250117C10000

Watchlist

1.00
+0.65+185.71%

15min DelayClose Jan 2 16:00 ET

1.10High1.00Low

Intraday

5D
Daily

News

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire16:15 ET
Certara Participates in a Conference Call With Jefferies
TipRanksDec 18, 2024 12:55 ET
Certara | 10-K/A: Annual report (Amendment)
SECDec 16, 2024 16:39 ET · Announcements
Medical Writing Market Size Indicating $ 9.09 Billion by 2031, Featuring Profiles of Cactus Communications, Certara, Covance, Freyr Solutions, InClin Inc
PR NewswireDec 13, 2024 11:00 ET
Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)
Simply Wall StDec 5, 2024 06:41 ET
Certara Showcases 2024 Research Wins With Over 100 Papers Published
GlobeNewswireDec 2, 2024 16:15 ET

Comments

Moomoo AI

Mar 21, 2024 09:18

The fact that Certara is now generating some pre-tax profits from its prior investments is very encouraging. The promising trends warrant this stock for further investigation despite its current low returns compared to the industry average.

Returns At Certara (NASDAQ:CERT) Are On The Way Up

Moomoo AI

Dec 13, 2023 15:33

Acquisition of Applied BioMath by Certara could enhance QSP biosimulation adoption in life sciences, revolutionizing drug invention. This may impact the drug discovery process, improving decisions and reducing late stage attrition rates.

Press Release: Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Moomoo AI

Oct 31, 2023 06:27

Amid less promising revenue projections, Certara's surprisingly high P/S ratio indicates investor hopes for a business rebound. However, analysts remain skeptical, suggesting shareholders may face disappointment if the P/S ratio rebalances with growth outlook.

Certara, Inc.'s (NASDAQ:CERT) Price Is Out Of Tune With Revenues

Movers and Shakers

Aug 22, 2023 07:21

Columns Today's Pre-Market Stock Movers And Top Ratings: ZM, LOW, EMR, MDT and More

Pre-Market Stock Movers
Gapping up
$Fabrinet (FN.US)$
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Applovin (APP.US)$
...